Paras Healthcare Reports Robust Q2 & H1 FY27 Results Post Successful Listing
Paras Healthcare Limited · Investor Presentation · 06 Nov 2026, 6:16 pm
Paras Healthcare Reports Robust Q2 & H1 FY27 Results Post Successful Listing Paras Healthcare, listed on 28th Oct'26, reported strong Q2 FY27 revenue growth of 22.8% YoY to ₹510.9 Cr, with operating EBITDA rising 47.0% YoY to ₹120.2 Cr (margin up 390 bps to 23.5%) and PAT surging 3.3x YoY to ₹40.4 Cr. For H1 FY27, revenue reached ₹981.2 Cr (+25.1% YoY) and PAT surged 7.9x to ₹90.0 Cr. Operational bed occupancy improved to 73.0% (vs 59.0% in H1 FY26) alongside ARPOB of ₹48.9k. IPO proceeds reduced pro-forma net debt to ₹143.0 Cr (0.15x net debt/equity).
Original exchange filing (PDF)
More announcements from Paras Healthcare Limited
- Transcript of the Earnings Conference Call held to discuss the Financial Results of the Company for the Quarter and half year ended September 30, 2026 · 13 Nov 2026
- Schedule of Investor Meet under Regulation 30 of SEBI Listing Regulations · 12 Nov 2026
- Audio Recording of Earnings Call on Financial Results of the Company for the Quarter and Half Year ended September 30, 2026 · 07 Nov 2026
- Disclosure under Regulation 30 of Listing Regulation · 06 Nov 2026
- Paras Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company. · 06 Nov 2026
- Press Release - Paras Health Reports robust revenue growth of 23% in Q2 YoY to Rs. 511 Cr. ; EBITDA up 43% YoY; PAT up 3.3x YoY · 06 Nov 2026
- Board Approved Unaudited Financials Results for Quarter and Half Year ended September 30, 2026 · 06 Nov 2026
- Paras Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 06 Nov 2026
